<i>miR-29</i> modulates CD40 signaling in chronic lymphocytic leukemia by targeting TRAF4: an axis affected by BCR inhibitorsSonali Sharma, Marek Mráz, Stacey M. Fernandes et al.|Blood|2021Cited by 63